Markets
Formula 2 Championship - Round 8 Silverstone - Feature Race
Hometown skeptics called it Champagne problems (Malcolm Griffiths/Getty Images)

How some US companies are turning a potential tariff hangover into an even bigger profit party

By preparing for the worst, these management teams no longer have to hope for the best.

Luke Kawa
7/23/25 10:41AM

By preparing for the worst, some of America’s leading companies no longer have to hope for the best.

Sam Rines, macro strategist at WisdomTree and the brains behind its GeoAlpha Opportunities Fund, has a brilliant thesis that helps explain one of the thornier questions in markets: how have stocks done so well, and earnings estimates held up so much, despite a big rise in tariff rates (albeit in many cases not as bad as what was floated on April 2)?

One could be pithy and just say “AI,” but that would be incomplete.

Rines is one of my favorite strategists for the way he scours micro information from companies to inform macro, top-down views about the economy and financial markets, and his work in unpacking how management teams are adapting to tariffs of an unknown size and scope is a great example of just this.

Here’s an excerpt from his recent note:

“Then there are the companies with too much tariff priced in. And those are the ones to watch. Again, there is a particular cadence to the companies —

- Guided for the worst of all possible worlds. (the reverse Leibniz guide)

- Found out it was not quite that bad after various tariff announcements and internal adjustments.

- Are now guiding some of the impact back to the bottom line. (emerged from the Dark Night of Earnings)”

One thing that blue-chip companies are very good at is overcoming shocks. I mean, look at the chart:

(It helps that the ones that aren’t get expunged from the index and replaced by firms that are!)

When you tell management teams that they’re about to have a 500-pound cross to bear, they’ll prepare. And when that turns out to be 350 pounds, they’ll be able to run a sub-three-hour marathon carrying it.

Rines highlights a few examples of this phenomenon during this earnings season. The best one, without a doubt, is 3M.

“Guiding down the tariff impact from $0.20 to $0.40 of net impact to $0.10 might sound trivial,” he wrote. “But the interaction of expecting a larger impact and preparing for it led 3M to guide earnings higher than their pre-tariff (January) expectation.”

3M earnings presentation
Source: 3M earnings presentation

Now, does this hold as a general rule? That’s a little tough to disentangle (and the answer is probably not). S&P 500 2025 earnings-per-share estimates are well below where they started the year. There is a tendency for calendar-year earnings to be revised lower within the year, though. So I’m not prepared to say (nor is Rines!) that tariffs are outright positive for earnings. But based on his work, I am fairly confident in concluding that tariffs provided a kick in the rear end that catalyzed some executive teams to make decisions that are boosting the profitability of their businesses.

Rines highlights Procter & Gamble, Deere & Co., and Kimberly-Clark as some of the stocks to watch to observe how widespread this dynamic may be.

“There are plenty of companies with a tariff overhang. For some, that hangover will be warranted. But others will emerge on the other side with better outcomes,” he concluded. “It may be surprising to see who the winners are at the end of earnings season. With tariff impacts being mitigated and pricing plans to come, this earnings season could be surprisingly positive.”

(Somehow, we got through this piece without referencing the apocryphal and not quite correct quote from JFK about how the Chinese word for crisis is composed of “danger” and “opportunity.”)

More Markets

See all Markets
markets

Tempus AI jumps on FDA clearance of AI-enabled tool to analyze cardiac MRIs

Tempus AI, a midcap medical diagnostics company that’s highlighted a push to incorporate AI technology into its products, surged on Thursday after announcing the FDA had issued a “510(k) clearance” of a new AI-enabled tool to analyze cardiac imagery from MRIs.

A 510(k) clearance — used for devices that are considered relatively low risk — essentially allows a product to be sold in the US.

While the company has never turned a profit, even on an adjusted basis, its sales are growing rapidly and the stock has had a great year, rising more than 160% in 2025.

For more on the company, check out our interview with its CEO, Eric Lefkofsky.

While the company has never turned a profit, even on an adjusted basis, its sales are growing rapidly and the stock has had a great year, rising more than 160% in 2025.

For more on the company, check out our interview with its CEO, Eric Lefkofsky.

markets

Micron surges as Citi boosts price target to $175

Micron is on the move this morning, gapping higher and continuing to trade up double digits after Citi boosted its view on how much the shares can run.

Analyst Christopher Danely raised his price target on the memory chipmaking specialist to $175 from $150, while maintaining a “buy” rating. The average analyst price target of $151 has now been shattered by Micron’s rise today, and the stock is trading at its highest level since June 2024.

This continues Micron’s advance as OpenAI’s dogged determination to burn through cash to enhance its AI capabilities provides a broad lift to the space, punctuated by Oracle’s massive gain on Wednesday.

Call demand is running hot: just 13 minutes into the session, volumes are running at 106,157 compared to a 20-day average of 88,888.

Micron is slated to report quarterly results on September 23.

markets

Centene rises after affirming full-year guidance

Centene soared in early trading after affirming its full-year guidance ahead of the Deutsche Bank 2025 Healthcare Summit on Thursday.

The company reiterated its expectation for adjusted diluted earnings per share to be approximately $1.75. At the conference, Centene executives also said they expect a higher percentage of its Medicare enrollees to be on more lucrative, top-rated plans next year, according to Bloomberg.

Earlier this week, UnitedHealth also reiterated its guidance and said it expects to have more top-rated plans in the coming year. The government rates insurance companies offering Medicare Advantage plans, and higher-rated plans are eligible for bonuses that can significantly increase a plan’s revenue.

Insurance companies that sell government-sponsored plans took a dive earlier this year amid unexpected rising costs. The recent announcements from both Centene and UnitedHealth may be a sign that the worst is behind them.

markets

Delta boosts its third-quarter sales outlook on improved travel demand

Delta Air Lines reaffirmed its full-year earnings outlook on Thursday, seeing US travel demand hold strong for the rest of the year.

Citing “improved demand trends,” the airline also elevated its sales forecast for the third quarter to an increase of between 2% and 4%. In July, it guided for 0% to 4% growth.

The move marks a turnaround from just five months ago, when Delta and many of its rivals pulled their full-year earnings outlooks as growth stalled on “broad economic uncertainty.” At the beginning of the year, Delta said 2025 had the chance to be its best fiscal year in a century.

After plunging earlier this year, Delta’s shares are essentially flat in 2025.

markets

Oracle’s rally briefly made cofounder Larry Ellison the world’s richest person, ahead of Elon Musk

Oracle pulled off one of the biggest rallies in its stock market history, as shares soared 36% on Wednesday after the company laid out a cloud business growth forecast that left analysts blown away.

What also went vertical, alongside the stock, was cofounder Larry Ellisons fortune.

According to the Bloomberg Billionaires Index, Ellisons net worth jumped by a record $89 billion to $383 billion, the biggest single-day gain ever, briefly overtaking Elon Musks fortune and making him, for a moment, the worlds richest person. Musk reclaimed the top spot by the end of Wednesday.

Yesterday’s remarkable gain means that Larry Ellison has now seen his estimated wealth increase by $191 billion year to date. That’s the equivalent of making $752 million a day, more than $522 thousand a minute, or $8,703 per second.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.